Renal Medullary Carcinoma: The Bronx Experience

Urology

Volumn 70, Issue 5, 2007, Pages 878-882

  Hakimi, A Ari ^a   Koi, Phillip T ^a   Milhoua, Paul M ^a   Blitman, Netta M ^a   Li, Maomi ^a   Hugec, Vladimir ^b   Dutcher, Janice P ^b   Ghavamian, Reza ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b OUR LADY OF MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; INTERLEUKIN 2; PACLITAXEL; SORAFENIB;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; FLANK PAIN; FOLLOW UP; HEMATURIA; HUMAN; KIDNEY CARCINOMA; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOGRAPHY; RETROSPECTIVE STUDY; SICKLE CELL; TUMOR BIOPSY;

ADOLESCENT; ADULT; CARCINOMA, MEDULLARY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEW YORK; RETROSPECTIVE STUDIES;

EID: 36549034353     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.06.1124     Document Type: Article

References (17)

1. Davis C.J.J., Mostofi F.K., and Sesterhenn I.A. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 19 (1995) 1-11
2. Davidson A.J., Choyke P.L., Hartman D.S., et al. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 195 (1995) 83-85
3. Wesche W.A., Wilmas J., Khare V., et al. Renal medullary carcinoma: a potential sickle cell nephropathy of children and adolescents. Pediatr Pathol Lab Med 18 (1998) 97-113
4. Avery R.A., Harris J.E., Davis C.J.J., et al. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 78 (1996) 128-132
5. Figenshau R.S., Basler J.W., Ritter J.H., et al. Renal medullary carcinoma. J Urol 159 (1998) 711-713
6. Blitman N.M., Berkenblit R.G., Rozenblit A.M., et al. Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol 185 (2005) 268-272
7. Swartz M.A., Karth J., Schneider D.T., et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60 (2002) 1083-1089
8. Yang X.J., Sugimura J., Tretiakova M.S., et al. Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer 100 (2004) 976-985
9. Castro O., Rana S.R., Bang K.M., et al. Age and prevalence of sickle-cell trait in a large ambulatory population. Genet Epidemiol 4 (1987) 307-311
10. Noguera-Irizarry W.G., Hibshoosh H., and Papadopoulos K.P. Renal medullary carcinoma: case report and review of the literature. Am J Clin Oncol 26 (2003) 489-492
11. Simpson L., He X., Pins M., et al. Renal medullary carcinoma and ABL gene amplification. J Urol 173 (2005) 1883-1888
12. Ataga K.I., and Orringer E.P. Renal abnormalities in sickle cell disease. Am J Hematol 63 (2000) 205-211
13. Ryan H.E., Lo J., and Johnson R.S. HIF-alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17 (1998) 3005-3015
14. Khan A., Thomas N., Costello B., et al. Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol 35 (2000) 1-7
15. Stahlschmidt J., Cullinane C., Roberts P., et al. Renal medullary carcinoma: prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of BCR/ABL rearrangement. Med Pediatr Oncol 33 (1999) 551-557
16. Motzer R.J., Bacik J., Mariani T., et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20 (2002) 2376-2381
17. Chow L.Q., and Eckhardt S.G. Sunitinib: from rational design to clinical efficacy. J Clin Oncol 25 (2007) 884-896